/MEDP

MEDP Stock - Medpace Holdings, Inc.

Q: What is the analyst price target for MEDP?

Analyst price target information is not currently available for MEDP.

Q: What is MEDP's market cap?

Market capitalization information is not currently available for MEDP.

Healthcare|Medical - Diagnostics & Research|NASDAQ

$608.43+1.54%

+$9.22 (+1.54%) • Jan 13

GoAI Score

Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.

HOLD

Medium Confidence

Momentum

Momentum Score

Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.

Sentiment

Sentiment Score

Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).

Risk Score

Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.

Price Target

Average analyst price target from the last quarter. Shows expected upside/downside from current price.

+-1.9%upside

Target: $596.87

AI Analysis PreviewPremium

Real-time AI-powered market analysis

Precise entry/exit price targets

Risk assessment & position sizing

Unlock GoAI Insights for MEDP

Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.

Buy/Sell Signals

94% win rate on Alpha signals

Deep Analysis

Institutional-grade thesis

Real-Time Alerts

SMS & push notifications

Risk Scoring

Multi-factor analysis

Free 14-day trial • No credit card required

Financial Statements

Revenue & Profitability Trend

FY2020

FY2021

FY2022

FY2023

FY2024

← Swipe to see more →

Revenue

Net Income (Profit)

Net Loss

Key Metrics

Market CapN/A

P/E RatioN/A

Beta1.44

52W High$626.25

52W Low$250.05

Avg VolumeN/A

Income Statement (Fiscal Year)

Metric	FY2024	FY2023	FY2022	FY2021	FY2020
Revenue	$2.11B	$1.89B	$1.46B	$1.14B	$925.92M
Gross Profit	$656.30M	$524.50M	$432.44M	$328.15M	$278.73M
Gross Margin	31.1%	27.8%	29.6%	28.7%	30.1%
Operating Income	$446.87M	$336.82M	$278.70M	$198.62M	$167.04M
Net Income	$404.39M	$282.81M	$245.37M	$181.85M	$145.38M
Net Margin	19.2%	15.0%	16.8%	15.9%	15.7%
EPS	$13.06	$9.20	$7.57	$5.06	$4.07

Company Overview

Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, it offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. The company was founded in 1992 and is based in Cincinnati, Ohio.

Visit Website

Earnings History & Surprises

MEDP

Beat Rate

100%

Last 18 quarters

Avg Surprise

+16.0%

EPS vs Estimate

Beats / Misses

18/0

Last 12 quarters

Latest EPS

$3.86

Q4 2025

EPS Surprise History

Q1 24

+10.8%

$2.46vs$2.22

Q2 24

+29.6%

$3.20vs$2.47

Q3 24

+8.3%

$2.75vs$2.54

Q4 24

+8.3%

$3.01vs$2.78

Q1 25

+24.0%

$3.67vs$2.96

Q2 25

+19.9%

$3.67vs$3.06

Q3 25

+4.0%

$3.10vs$2.98

Q4 25

+10.3%

$3.86vs$3.50

Beat Estimate

Missed Estimate

Quarterly EPS Details

Period	Report Date	Estimated EPS	Actual EPS	Surprise	Result
Q2 2026	Apr 20, 2026	—	—	—	—
Q1 2026	Feb 9, 2026	$4.18	—	—	—
Q4 2025	Oct 22, 2025	$3.50	$3.86	+10.3%	✓ BEAT
Q3 2025	Jul 21, 2025	$2.98	$3.10	+4.0%	✓ BEAT
Q2 2025	Apr 21, 2025	$3.06	$3.67	+19.9%	✓ BEAT
Q1 2025	Feb 10, 2025	$2.96	$3.67	+24.0%	✓ BEAT
Q4 2024	Oct 21, 2024	$2.78	$3.01	+8.3%	✓ BEAT
Q3 2024	Jul 22, 2024	$2.54	$2.75	+8.3%	✓ BEAT
Q2 2024	Apr 22, 2024	$2.47	$3.20	+29.6%	✓ BEAT
Q1 2024	Feb 12, 2024	$2.22	$2.46	+10.8%	✓ BEAT
Q4 2023	Oct 23, 2023	$2.05	$2.22	+8.3%	✓ BEAT
Q3 2023	Jul 24, 2023	$1.91	$1.93	+1.0%	✓ BEAT
Q2 2023	Apr 24, 2023	$1.80	$2.27	+26.1%	✓ BEAT
Q1 2023	Feb 13, 2023	$1.79	$2.12	+18.4%	✓ BEAT
Q4 2022	Oct 24, 2022	$1.47	$2.05	+39.5%	✓ BEAT
Q3 2022	Jul 25, 2022	$1.31	$1.46	+11.5%	✓ BEAT
Q2 2022	Apr 25, 2022	$1.26	$1.69	+34.1%	✓ BEAT
Q1 2022	Feb 14, 2022	$1.25	$1.32	+5.6%	✓ BEAT
Q4 2021	Oct 25, 2021	$1.07	$1.29	+20.6%	✓ BEAT
Q3 2021	Jul 26, 2021	$0.99	$1.06	+7.1%	✓ BEAT

Frequently Asked Questions about MEDP

What is MEDP's current stock price?

Medpace Holdings, Inc. (MEDP) is currently trading at $608.43 per share. The stock has moved +1.54% today.

What is the analyst price target for MEDP?

The average analyst price target for MEDP is $597.17, based on 1 analyst.

What sector is Medpace Holdings, Inc. in?

Medpace Holdings, Inc. operates in the Healthcare sector, specifically within the Medical - Diagnostics & Research industry. The company is traded on the NASDAQ exchange.

What is MEDP's market cap?

Medpace Holdings, Inc. has a market capitalization of $17.14 billion, making it a large-cap company.

Does MEDP pay dividends?

No, Medpace Holdings, Inc. does not currently pay a dividend to shareholders.